Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-analysis

(2020) Giovana F Piccoli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Breast Cancer Treatment

(2019) Adrienne G. Waks et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epigenetics in Human Obesity and Type 2 Diabetes

(2019) Charlotte Ling et al.   Cell Metabolism

DNMT Inhibitors Increase Methylation in the Cancer Genome

(2019) Anil K. Giri et al.   Frontiers in Pharmacology

Glutathione system in animal model of solid tumors: From regulation to therapeutic target

(2018) Claudia Rita Corso et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic

(2018) Khushboo Agrawal et al.   PHARMACOLOGY & THERAPEUTICS

Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy

(2018) Sneha Mishra et al.   Scientific Reports

ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases

(2018) Verena Kirn et al.   CLINICAL & EXPERIMENTAL METASTASIS

Drug repurposing: progress, challenges and recommendations

(2018) Sudeep Pushpakom et al.   NATURE REVIEWS DRUG DISCOVERY

Is there an association between liraglutide use and female breast cancer in a real-world setting?

(2018) Donnie Funch et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis

(2017) Zhan Li et al.   Oncotarget

Down regulation of ADAM33 as a Predictive Biomarker of Aggressive Breast Cancer

(2017) Graciele C. M. Manica et al.   Scientific Reports

Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping

(2017) Xiaofeng Dai et al.   Journal of Cancer

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics

(2015) Lisbeth V. Jacobsen et al.   CLINICAL PHARMACOKINETICS

Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists

(2015) Sten Madsbad   DIABETES OBESITY & METABOLISM

Crystal Structure of Human DNA Methyltransferase 1

(2015) Zhi-Min Zhang et al.   JOURNAL OF MOLECULAR BIOLOGY

DNA Methyltransferases: A Novel Target for Prevention and Therapy

(2014) Dharmalingam Subramaniam et al.   Frontiers in Oncology

DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets

(2013) Elin Hall et al.   BMC Medical Genetics

A Flexible Mouse-On-Mouse Immunohistochemical Staining Technique Adaptable to Biotin-Free Reagents, Immunofluorescence, and Multiple Antibody Staining

(2013) Tracy Goodpaster et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project

(2012) Rebecca J. Cleveland et al.   CANCER CAUSES & CONTROL

The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells

(2011) Hagai Ligumsky et al.   BREAST CANCER RESEARCH AND TREATMENT

Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer

(2010) Edneia AS Ramos et al.   BMC CANCER

Diabetes and Cancer: A consensus report

(2010) E. Giovannucci et al.   DIABETES CARE

ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma

(2009) Gerusa G Seniski et al.   BMC CANCER